About
A highly driven, innovative, and collaborative healthcare professional and leader with 30…
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
University of California, San Francisco
Activities and Societies: Rho Chi Honor Society, Phi Delta Chi Pharmacy Fraternity
UCSF, School of Pharmacy, Doctor of Pharmacy
-
-
-
Volunteer Experience
-
Volunteer Faculty, Assistant Clinical Professor, School of Pharmacy
University of California, San Francisco
- Present 31 years
Education
-
Member, AAUCSF Board of Directors
University of California, San Francisco
- Present 4 years 4 months
Health
-
AMCP Diplomat, UCSF School of Pharmacy
Academy of Managed Care Pharmacy
- Present 7 years 11 months
Health
Volunteer role to work with student chapter leaders and the chapter advisor to enhance the opportunities, experiences, and information offered to AMCP student pharmacist members.
-
-
Member, AMCP Format Executive Committee
Academy of Managed Care Pharmacy
- 10 years 11 months
Health
THE ROLE OF THE AMCP FORMAT: The evidence requirements contained herein are intended for use by manufacturers of pharmaceuticals, biologics and vaccines who are responding to an unsolicited request from a healthcare system to support reimbursement and/or formulary placement consideration of a new product, new indication, or new formulation of an existing product. The Academy of Managed Care Pharmacy (AMCP) and the Foundation for Managed Care Pharmacy (FMCP) gratefully acknowledge the…
THE ROLE OF THE AMCP FORMAT: The evidence requirements contained herein are intended for use by manufacturers of pharmaceuticals, biologics and vaccines who are responding to an unsolicited request from a healthcare system to support reimbursement and/or formulary placement consideration of a new product, new indication, or new formulation of an existing product. The Academy of Managed Care Pharmacy (AMCP) and the Foundation for Managed Care Pharmacy (FMCP) gratefully acknowledge the contributions of many individuals who have devoted substantial time, expertise and commitment in the preparation of the 3rd revision the AMCP Format for Formulary Submissions.
http://www.amcp.org/AMCPFormatforFormularySubmissions/ -
-
-
Lead Pharmacist, DMAT CA-6 / NDMS / DHHS
U.S. Department of Health and Human Services (HHS)
- 16 years 1 month
Disaster and Humanitarian Relief
Disaster Medical Assistance Team (DMAT) CA-6 is a federal disaster medical team under the US Department of Health and Human Services' (DHHS) National Disaster Medical System (NDMS). The team responds to federally-declared disasters and incidents of national significance, providing medical care to disaster victims under austere, post-disaster conditions.
-
Reserve Police Officer
City & County of San Francisco - Police Department (SFPD)
- 7 years
Peace Officer Standards and Training (POST) Level II
College of San Mateo, completed May 2006
Peace Officer Standards and Training (POST) Level III
College of San Mateo, completed May 2005
-
Board Member, Alumni Association
University of California, San Francisco
- 2 years 1 month
Education
-
Volunteer Pharmacist
National Pharmacists Response Team (NPRT) Region IX / NDMS / USDHS
- 3 years 2 months
Disaster and Humanitarian Relief
Publications
-
RealPharma Podcast: Decoding HEOR: Iris Tam's Insights on Pharma's Value-Based Future
RealPharma Podcast
HEOR (Health Economics and Outcomes Research) plays an increasingly important role in the success of a pharma brand, but the complexities and strategic considerations can be challenging to navigate.
We recently had the chance to discuss this with the remarkable Iris Tam, PharmD, who works at COEUS. In this episode, Na-Ri Oh and I explore with Iris the critical role of HEOR in transforming today's pharmaceutical landscape, from drug development to global marketing strategies and…HEOR (Health Economics and Outcomes Research) plays an increasingly important role in the success of a pharma brand, but the complexities and strategic considerations can be challenging to navigate.
We recently had the chance to discuss this with the remarkable Iris Tam, PharmD, who works at COEUS. In this episode, Na-Ri Oh and I explore with Iris the critical role of HEOR in transforming today's pharmaceutical landscape, from drug development to global marketing strategies and beyond.
Listen here: https://lnkd.in/g9K5YyVk
Unpacking the complexities of HEOR, we delve into its definition, significance, and the evolving importance of this field in aligning drug development with payer expectations and patient outcomes. Iris shares invaluable insights on the key elements that payers scrutinize in HEOR studies, and the strategic considerations essential for successful global product launches.
Ethical considerations in HEOR research also take center stage, highlighting the responsibility of ensuring integrity and patient-centricity in evidence generation. We hope you can join us for this fascinating discussion!
Listen here: https://lnkd.in/g9K5YyVk
RealPharma LinkedIn Group: https://lnkd.in/dRfKg2XKOther authors -
-
Industry Diagnostic Test Information Provision Versus Expectations
Journal of Managed Care and Specialty Pharmacy
See publicationIn link above, bottom of page S28 (pdf page 30).
Projects
-
Health Care Resource Utilization Associated with Tympanostomy Tube Placement in Pediatric Patients
BACKGROUND
Otitis media (OM) with effusion (OME) occurs in 90% of children by age 4. Chronic OME may lead to hearing loss; speech, language, and learning difficulties; decreased quality of life; and increased health care utilization. Tympanostomy tube (TT) placement is an established treatment for chronic OME, however otorrhea (or tube otorrhea) is the most common post-TT sequalae. Although not FDA-approved nor supported by national guidelines, antibiotic eardrops are routinely applied…BACKGROUND
Otitis media (OM) with effusion (OME) occurs in 90% of children by age 4. Chronic OME may lead to hearing loss; speech, language, and learning difficulties; decreased quality of life; and increased health care utilization. Tympanostomy tube (TT) placement is an established treatment for chronic OME, however otorrhea (or tube otorrhea) is the most common post-TT sequalae. Although not FDA-approved nor supported by national guidelines, antibiotic eardrops are routinely applied during and after TT placement to prevent tube otorrhea. For otorrhea that occurs at any time with tubes in place, the American Academy of Otolaryngology (AAO) clinical practice guidelines recommend topical antibiotics (eardrops), not oral, to treat tube otorrhea. Antibiotic eardrops are indicated for the treatment of patients with acute OM with tubes (AOMT).
OBJECTIVE
To characterize the use of prescription antibiotics during the month following tympanostomy tube placement in pediatric patients, and to compare prescription antibiotic use in Medicaid-enrolled and commercially insured populations.
IM Tam, SD Candrilli, JR Moss. Health Care Resource Utilization Associated with Tympanostomy Tube Placement in Pediatric Populations. AMCP Managed Care & Specialty Pharmacy Annual Meeting. Abstract H04. JMCP. April 2016;22(4-a):S80-S81.Other creators -
-
Systematic Review of Published Pharmacoeconomic Models
-
In order to understand and improve payers' experience with economic data we carried a systematic review of pharmacoeconomic models in the peer-reviewed medical literature and characterized its potential usefulness for Healthcare Decision Makers (HCDMs) in making formulary decisions. The disease area selected for this systematic review was multiple sclerosis (MS).
Other creators -
-
Systematic Review of Published Pharmacoeconomic Models
-
In order to understand and improve payers' experience with economic data we carried a systematic review of pharmacoeconomic models in the peer-reviewed medical literature and characterized its potential usefulness for Healthcare Decision Makers (HCDMs) in making formulary decisions. The disease area selected for this systematic review was multiple sclerosis (MS).
Other creators -
Honors & Awards
-
Spirit of Volunteerism Award
Academy of Managed Care Pharmacy (AMCP)
Recognizes a current AMCP Committee Member who has demonstrated outstanding service to AMCP over the past year, and provided volunteer activities that resulted in successful and/or high quality AMCP programs, projects and/or services for our members.
-
Fellow, Academy of Managed Care Pharmacy (FAMCP)
Academy of Managed Care Pharmacy (AMCP)
-
Best New Investigator Poster Presentation
International Society of Pharmacoeconomics & Outcomes Research (ISPOR)
Research: Characterizing Emergency Department Utilization Among Pediatric Patients with Tympanostomy Tubes
-
Honorable Mention, Bowl of Hygeia
UCSF School of Pharmacy
Languages
-
Chinese Cantonese
-
Organizations
-
Academy on Managed Care Pharmacy (AMCP)
-
-
American Society of Health-Systems Pharmacists (ASHP)
-
-
Drug Information Association (DIA)
-
-
Guidelines International Network (G-I-N)
-
-
International Society for Pharmcoeconomics and Outcomes Research (ISPOR)
-
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Iris Tam in United States
-
Iris Tam
Senior Director of Business Planning at NetSuite
-
Iris Tam
-
Iris Tam
Sr. Mortgage Loan Officer with LoanDepot
-
Iris Tam
8 others named Iris Tam in United States are on LinkedIn
See others named Iris Tam